Getting an extra dose out of a Wegovy pen: what the evidence says and what to do instead

What the pen's design actually tells us

Wegovy's pre-filled auto-injector is engineered around a single measured delivery. The plunger mechanism, the needle length, and the dose-lock system are all built to release one precise volume of semaglutide solution. Once the injection is complete, the pen locks. That is not a quirk of manufacturing; it is a deliberate patient-safety feature validated across Novo Nordisk's clinical programme, including the STEP 1 trial published in the New England Journal of Medicine, where consistent, device-delivered dosing was central to achieving an average 15% reduction in body weight over 68 weeks.

People sometimes ask whether residual liquid visible in the pen after injection means a dose has been missed or wasted, and if you want a detailed walkthrough of what is actually happening inside the device, our guide on how to get the golden dose out of your Wegovy pen explains it step by step. Some medicine remains in the needle and the dead-space of the device by design; this accounts for the manufacturing tolerances that guarantee the labelled dose reached you. Trying to extract that residual liquid with a syringe or by any other means would not give you a usable therapeutic dose. It would give you an unknown quantity of medicine that has been drawn through a compromised sterile barrier.

A question our prescribers hear most weeks is whether waiting longer on a starter dose to stretch supply is a reasonable workaround. It is not a clinical shortcut we can endorse; titration timing is set by the prescriber, and unilaterally extending time at a lower strength delays the clinical benefit without making your supply go further in any meaningful way. The right conversation is with your prescriber, ideally a few days before you expect to run short.

Eligibility for Wegovy on a private prescription, and how supply is managed at the consultation stage

Wegovy is licensed in the UK for adults with a BMI of 30 or above, or from 27 upwards where at least one weight-related condition is present, such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. Eligibility is assessed in full at the consultation, BMI alone does not guarantee a prescription, and the prescriber considers your full health picture.

Supply continuity is one of the practical things a prescriber factors in. When you reorder through a regulated service, your prescriber reviews your progress and your dose before each supply goes out. That is also the moment to flag any concern about supply gaps. You can read more about the process for getting Wegovy in the UK, including what the consultation covers, if you are earlier in that journey.

On the NHS, Wegovy is recommended by NICE (TA875) for use within specialist weight management services, with specific criteria around comorbidities and a two-year treatment limit; waiting lists are often long. Private prescriptions through a registered pharmacy are the alternative for people who do not meet NHS criteria yet, or who prefer not to wait. The NICE appraisal of semaglutide sets out the full NHS criteria if you want to read them directly.

Buying Wegovy safely: what a legitimate supply chain looks like

Because Wegovy is a prescription-only medicine, the only legal route to it in the UK is through a prescriber and a pharmacy registered with the General Pharmaceutical Council. You can check any online pharmacy on the GPhC register in under a minute; our GPhC premises number is 9012878 if you want to verify us that way.

The MHRA has repeatedly warned about counterfeit weight-loss pens circulating online and through social media. Roughly 20 million doses of illegally traded weight-loss medicines, with an estimated street value of around £45 million, were seized in 2025 alone. Fake pens have been found to contain insulin rather than semaglutide, which poses a serious risk. The red flags are consistent: sellers offering these medicines without a prescription, prices far below what a legitimate supply chain can sustain, and discount codes from unverified sources. If you encounter those, report the seller via the MHRA Yellow Card scheme. The same platform lets you report any suspected side effect from a medicine you are already taking.

If you are weighing up where to get your prescription, the page on buying Wegovy in the UK covers what to look for in a regulated provider, and what questions are worth asking before you commit. And if you are already on treatment and want to make the most of it, there is practical guidance on getting the best out of Wegovy that is worth a read alongside your Patient Information Leaflet.

What to do right now if you are concerned about your current pen or supply

If you believe your pen malfunctioned and did not deliver a full dose, do not attempt a second injection. Contact your prescriber or the pharmacy that dispensed it the same day. The NHS semaglutide guidance is clear that missed or uncertain doses should be discussed with a healthcare professional, not self-managed. A pen that appeared to malfunction should be kept, if possible, so the pharmacist or prescriber can assess what happened, and if you have questions about the needles themselves, our page on whether you can buy extra needles for your Wegovy pen covers your options.

If you are simply running low and worried about a gap, place your reorder a few days ahead of running out. At nume, reorders are reviewed by a prescriber before dispatch, that review is also the right moment to discuss whether your current dose is still the right one, or whether a change is due, and our guide on how to get the most out of Wegovy is a useful read while you wait for that conversation. You can explore the full range of options on our treatment page or contact our aftercare team through the contact page if something more urgent has come up. Aftercare is available seven days a week. That is the service part of a clinician-led prescription, supply questions belong there, not in a search engine.